£47.99m
+45%vs Dec 2024Active13758641Private limited companyLondon
CONSTRUCTIVE BIOLOGY LIMITED
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Coming soon · product and service lists
What does Constructive Biology Limited sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01
Summary
CONSTRUCTIVE BIOLOGY LIMITED is an active private limited company (company number 13758641) incorporated on 22 November 2021, registered in London. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest full accounts cover the period ending 31 December 2025, showing net assets of £47.99m and cash of £45.23m, with 46 employees on average. Turnover was £10.78m and profit for the year −£525k. Net assets rose 45% on the prior period (£33.13m).
Peer position · net assets
By net assets it sits in the top quarter of 603 comparable companies in London (median £440, upper quartile £92k).
02
Ownership and control
No active person with significant control is registered.
- Dr Jason William Karl Chin
- owns 75–100% of shares
- holds 75–100% of voting rights
- can appoint or remove directors
- Amadeus Capital Partners Limited
- holds 25–50% of voting rights
- Amadeus V Technology Gp Lp
- owns 25–50% of shares
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
03
Key dates
- Incorporated
- 22 November 20214 yrs ago
- Next accounts due
- 30 September 2027in 342 days
- Confirmation statement due
- 6 December 2026in 44 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
04
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Full
- Size band
- SmallCompanies Act thresholds
05
Financials
£45.23m
+44%vs Dec 2024£10.78m
vs Dec 202446
+64%vs Dec 2024| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 December 2025 | £47.99m | £45.23m | — | — | £10.78m | −£525k | 46 |
| 31 December 2024 | £33.13m | £31.36m | — | — | £0 | −£5.63m | 28 |
| 30 November 2023 | — | — | — | — | — | — | — |
Net margin-4.9%Profit for the year ÷ turnover
Cash per employee£983kCash ÷ average employees
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
06
Filing and accounts signals
- Net assets above zeroNet assets £47,985,975 at 31 December 2025
- Net assets up 10% or more on the prior period+44.8% vs prior period
- Cash at bank of £50,000 or moreCash £45,230,269
- Three or more accounting periods on record3 periods on record
- Incorporated two to five years agoIncorporated 22 November 2021
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
07
Timeline
- Next accounts duein 342 days
- Confirmation statement duein 44 days
- Accounts period endNet assets £47.99m · full accounts
- Accounts period endNet assets £33.13m · full accounts
- Accounts period end
- Incorporated
08
Similar companies in London
- SANIA TX LTDLondon · inc. Nov 2021
- TRIPLE HELIX BIOTECHNOLOGY LTDLondon · inc. Nov 2021
- LYRA PHARMA LIMITEDLondon · inc. Nov 2021
- MENDEA TECHNOLOGIES LIMITEDLondon · inc. Nov 2021
- LIBERUM HEALTH LTDLondon · inc. Nov 2021
- UK NIVD LTDLondon · inc. Nov 2021
All companies incorporated on 22 November 2021 · in Nov 2021.
09
Reminders for CONSTRUCTIVE BIOLOGY LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.